a. Compute the relative risk of coronary artery disease in patients receiving the new cholesterol medication as compared to those receiving a placebo.
b. Compute the odds ratio of coronary artery disease in patients receiving the new cholesterol medication as compared to those receiving a placebo.
c. Which measure is more appropriate in this design, the relative risk or odds ratio? Justify briefly.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here